Urinary Urgency Incontinence

3

Review clinical trials related to Urinary Urgency Incontinence. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

To assess the post-market clinical outcomes of the Axonics SNM System for treatment of overactive bladder in male patients.

Participants needed: 150
Trial details
Age: 18+Biological sex: MaleType: InterventionalSponsor: Axonics, Inc.Updated: Jul 13, 2026Locations: 21
Eligibility criteria

Participants aged ≥ 18 years at the time of enrollment [+3]

Any patient that is not a suitable candidate per investigator discretion [+9]

Status: Recruiting

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

To assess the post-market clinical outcomes of the Axonics SNM System for treatment of overactive bladder in male patients.

Participants needed: 150
Trial details
Age: 18+Biological sex: MaleType: InterventionalSponsor: Axonics, Inc.Updated: Jun 15, 2026Locations: 20
Eligibility criteria

Participants aged ≥ 18 years at the time of enrollment [+3]

Any patient that is not a suitable candidate per investigator discretion [+9]

Status: Recruiting

Post-Approval Study of the Neuspera Sacral Neuromodulation System

Prospective, multi-center, single-arm, post-approval study is designed to assess the long-term safety and efficacy data of the Neuspera Sacral Neuromodulation (SNM) System following commercial approval of the Neuspera SNM System. Participants in this study received intervention/implanted in Phase I or Phase II of the Neuspera SANS\_UUI (NSM-004) Study.

Participants needed: 116
Trial details
Age: 22+Biological sex: AllType: InterventionalSponsor: Neuspera Medical, Inc.Updated: Feb 4, 2026Locations: 20
Eligibility criteria

Subjects in the SANS-UUI Phase I or Phase II study

None